Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study
Charilaos Chourpiliadis(Karolinska Institutet), Fang Fang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yihan Hu(Karolinska Institutet), Anikó Lovik(Leiden University), Kristin Samuelsson(Karolinska University Hospital), Caroline Ingre(Karolinska University Hospital), Ulf Kläppe(Karolinska University Hospital), Lu Pan(Karolinska Institutet), Emily E. Joyce(Karolinska Institutet), Rayomand Press(Karolinska University Hospital), Christina Seitz(Karolinska Institutet)
Cited by 7
Related Papers
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
|Journal of Clinical Oncology|2009|245
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
|Journal of Clinical Oncology|2010|217
Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders
|JAMA Network Open|2024|139
Mediterranean diet and depression: a population-based cohort study
|International Journal of Behavioral Nutrition and Physical Activity|2021|138